Description

CJC-1295 No DAC (5mg / 10mg)

CJC-1295 No DAC is a synthetic analog of growth hormone–releasing hormone (GHRH) designed for laboratory investigation of endogenous growth hormone (GH) signaling pathways. It binds to GHRH receptors located in the anterior pituitary, initiating intracellular signaling that stimulates the release of growth hormone within controlled research environments.

Unlike DAC-modified versions, the No DAC formulation does not include a Drug Affinity Complex, meaning it does not bind to serum albumin. This results in a shorter activity window, making it suitable for research models focused on pulsatile GH release dynamics and time-sensitive endocrine signaling analysis.

CJC-1295 No DAC is available in both 5mg and 10mg vial options to accommodate varying research protocols.

This product is intended strictly for laboratory and scientific research use.

Mechanism of Action (Research Overview)

GHRH Receptor Activation

CJC-1295 No DAC binds to growth hormone–releasing hormone receptors in the anterior pituitary. Activation of these receptors stimulates endogenous GH secretion through intracellular cAMP signaling pathways.

Pulsatile GH Secretion Modeling

Due to the absence of DAC modification, this version is commonly studied for its shorter half-life and ability to support controlled investigation of GH pulsatility patterns within experimental models.

Downstream Biomarker Evaluation

Research protocols frequently measure downstream biomarkers such as:

• Insulin-like Growth Factor 1 (IGF-1)

• IGF Binding Protein-3 (IGFBP-3)

• Endocrine feedback loop dynamics

These endpoints allow researchers to assess GH-axis signaling under controlled conditions.

Research Focus Areas

CJC-1295 No DAC has been explored in laboratory environments involving:

• Endogenous growth hormone secretion modeling

• GH pulsatility and timing analysis

• IGF-1 biomarker tracking

• Pituitary receptor selectivity studies

• Metabolic and endocrine signaling pathway research

• Hypothalamic–pituitary axis dynamics

These research focus areas reflect measurable endpoints evaluated in scientific literature and are provided for informational context only.

Key Research Characteristics

• Synthetic GHRH analog

• No DAC modification (short-acting formulation)

• Studied for pituitary receptor activation

• Frequently researched in GH-axis and endocrine signaling models

• Lyophilized (freeze-dried) for stability and storage

Product Specifications

• Compound: CJC-1295 No DAC

• Available Sizes: 5mg or 10mg vial

• Form: Lyophilized powder

• Purity: High-purity, lab-tested

• Storage: Store refrigerated after reconstitution

Why Fit Aminos

Fit Aminos supplies research-grade peptides manufactured under strict quality control standards to ensure purity, consistency, and reliability. Each batch is tested to support accurate and repeatable laboratory research outcomes.

Important Notice

This product is for research use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.